Replimune Group, Inc. (REPL)
7.77
+0.02
(+0.26%)
USD |
NASDAQ |
Feb 09, 16:00
7.77
0.00 (0.00%)
After-Hours: 20:00
Replimune Group EPS Diluted (Quarterly) : -0.7694 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| Verastem, Inc. | -1.347 |
| Sarepta Therapeutics, Inc. | -1.795 |
| Anavex Life Sciences Corp. | -0.1144 |
| Ocugen, Inc. | -0.066 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -70.93M |
| Total Expenses (Quarterly) | 70.93M |
| Enterprise Value | 447.15M |
| Earnings Yield | -46.11% |
| Normalized Earnings Yield | -46.11 |